Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Commits To Dual Branded And Generic Model
CEO Maintains ‘World Class’ Generics Business And Innovative Interests Are Complementary
Feb 23 2024
•
By
David Wallace
Richard Francis set out his thoughts on Teva’s business model
More from Strategy
More from Business